Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.

Ko BS, Chang CS, Chang MC, Chen TY, Chiou TJ, Chiu CF, Huang WL, Kao WY, Lan YJ, Lin SF, Tan TD, Tang JL, Tzeng CH, Wang PN, Yet SP, Tien HF.

Int J Hematol. 2014 Jul;100(1):7-15. doi: 10.1007/s12185-014-1607-x. Epub 2014 Jun 13.

PMID:
24924953
[PubMed - in process]
2.

IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.

Yang YT, Hou HA, Liu CY, Lin CC, Chou WC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Kuo YY, Huang SY, Ko BS, Chen CY, Hsu SC, Lin CT, Wu SJ, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 May 21. doi: 10.1002/ajh.23765. [Epub ahead of print]

PMID:
24845799
[PubMed - as supplied by publisher]
3.

SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution.

Lin CC, Hou HA, Chou WC, Kuo YY, Wu SJ, Liu CY, Chen CY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Hsu SC, Ko BS, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Aug;89(8):E109-15. doi: 10.1002/ajh.23734. Epub 2014 Apr 28.

PMID:
24723457
[PubMed - in process]
4.

MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.

Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI.

Leuk Res. 2014 May;38(5):625-31. doi: 10.1016/j.leukres.2014.03.008. Epub 2014 Mar 19.

PMID:
24703161
[PubMed - indexed for MEDLINE]
5.

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.

Huang SY, Lin CW, Lin HH, Yao M, Tang JL, Wu SJ, Chen YC, Lu HY, Hou HA, Chen CY, Chou WC, Tsay W, Chou SJ, Tien HF.

Ann Hematol. 2014 Aug;93(8):1371-80. doi: 10.1007/s00277-014-2063-7. Epub 2014 Apr 1.

PMID:
24687382
[PubMed - in process]
Free PMC Article
6.

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

Ogura M, Ando K, Suzuki T, Ishizawa K, Oh SY, Itoh K, Yamamoto K, Au WY, Tien HF, Matsuno Y, Terauchi T, Yamamoto K, Mori M, Tanaka Y, Shimamoto T, Tobinai K, Kim WS.

Br J Haematol. 2014 Jun;165(6):768-76. doi: 10.1111/bjh.12819. Epub 2014 Mar 12.

PMID:
24617454
[PubMed - in process]
7.

Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome.

Hou HA, Kuo YY, Chou WC, Chen PH, Tien HF.

Leukemia. 2014 Jul;28(7):1555-7. doi: 10.1038/leu.2014.71. Epub 2014 Feb 17. No abstract available.

PMID:
24531734
[PubMed - in process]
8.

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.

Chen TC, Hou HA, Chou WC, Tang JL, Kuo YY, Chen CY, Tseng MH, Huang CF, Lai YJ, Chiang YC, Lee FY, Liu MC, Liu CW, Liu CY, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Blood Cancer J. 2014 Jan 17;4:e177. doi: 10.1038/bcj.2013.74.

PMID:
24442206
[PubMed]
Free PMC Article
9.

Rapidly fatal leukemia comprising pleomorphic large granular lymphocytes: a report of 2 cases.

Win KT, Hsieh YC, Yang CC, Chang ST, Su YZ, Tien HF, Chuang SS.

Anal Quant Cytol Histol. 2013 Aug;35(4):232-6.

PMID:
24341127
[PubMed - indexed for MEDLINE]
10.

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.

Chen WY, Wang CW, Chang CH, Liu HH, Lan KH, Tang JL, Tien HF, Kuo SH, Cheng AL.

Radiat Oncol. 2013 Oct 22;8:245. doi: 10.1186/1748-717X-8-245.

PMID:
24148102
[PubMed - in process]
Free PMC Article
11.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Hou HA, Kuo YY, Tang JL, Chou WC, Yao M, Lai YJ, Lin CC, Chen CY, Liu CY, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Huang SY, Ko BS, Wu SJ, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Feb;89(2):181-6. doi: 10.1002/ajh.23611. Epub 2013 Nov 20.

PMID:
24127063
[PubMed - indexed for MEDLINE]
12.

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.

Lin CC, Hou HA, Chou WC, Kuo YY, Liu CY, Chen CY, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Ko BS, Wu SJ, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Feb;89(2):137-44. doi: 10.1002/ajh.23596. Epub 2013 Nov 20.

PMID:
24115220
[PubMed - indexed for MEDLINE]
13.

Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.

Lee MC, Kuo YY, Chou WC, Hou HA, Hsiao M, Tien HF.

J Leukoc Biol. 2014 Jan;95(1):105-15. doi: 10.1189/jlb.0912475. Epub 2013 Sep 9.

PMID:
24018353
[PubMed - indexed for MEDLINE]
14.

Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study.

Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL; Taiwan Cooperative Oncology Group.

Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14.

PMID:
24002804
[PubMed - in process]
15.

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.

Hou HA, Lin CC, Chou WC, Liu CY, Chen CY, Tang JL, Lai YJ, Tseng MH, Huang CF, Chiang YC, Lee FY, Kuo YY, Lee MC, Liu MC, Liu CW, Lin LI, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Leukemia. 2014 Jan;28(1):50-8. doi: 10.1038/leu.2013.236. Epub 2013 Aug 9.

PMID:
23929217
[PubMed - indexed for MEDLINE]
16.

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.

Wu SJ, Tang JL, Lin CT, Kuo YY, Li LY, Tseng MH, Huang CF, Lai YJ, Lee FY, Liu MC, Liu CW, Hou HA, Chen CY, Chou WC, Yao M, Huang SY, Ko BS, Tsay W, Tien HF.

Am J Hematol. 2013 Nov;88(11):E277-82. doi: 10.1002/ajh.23541. Epub 2013 Sep 3.

PMID:
23861105
[PubMed - indexed for MEDLINE]
17.

Clinical features of patients with infections caused by Candida guilliermondii and Candida fermentati and antifungal susceptibility of the isolates at a medical centre in Taiwan, 2001-10.

Chen CY, Huang SY, Tang JL, Tsay W, Yao M, Ko BS, Chou WC, Tien HF, Hsueh PR.

J Antimicrob Chemother. 2013 Nov;68(11):2632-5. doi: 10.1093/jac/dkt214. Epub 2013 Jun 13.

PMID:
23766486
[PubMed - indexed for MEDLINE]
18.

Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.

Wu SJ, Chiang CJ, Lin CT, Tien HF, Lai MS.

PLoS One. 2013 Apr 24;8(4):e62930. doi: 10.1371/journal.pone.0062930. Print 2013.

PMID:
23638168
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia.

Chen CY, Cheng A, Huang SY, Sheng WH, Liu JH, Ko BS, Yao M, Chou WC, Lin HC, Chen YC, Tsay W, Tang JL, Chang SC, Tien HF.

PLoS One. 2013;8(4):e60624. doi: 10.1371/journal.pone.0060624. Epub 2013 Apr 5.

PMID:
23577135
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis.

Chen CY, Chou WC, Tsay W, Tang JL, Yao M, Huang SY, Tien HF.

BMC Cancer. 2013 Mar 8;13:107. doi: 10.1186/1471-2407-13-107.

PMID:
23496932
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk